| Market Cap | ₹1,08,412Cr |
| ROE | 16.53% |
| P/E Ratio(TTM) | 23.91 |
| EPS(TTM) | 56.12 |
| P/B Ratio | 3.29 |
| Dividend Yield | 1.19% |
| Industry P/E | 32.40 |
| Book Value | 407.52 |
| Debt to Equity | 0.01 |
| Face Value | 2 |
| Managing Director | Mr Umang Vohra |
| Founded | 1935 |
| NSE Symbol | CIPLA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 37.41 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.98 | ||
| Lupin | NA (0.00%) | 23.17 | ||
| Zydus Lifesciences | NA (0.00%) | 17.76 |